<div id="readability-page-1">Bristol-Myers Squibb (BMY) shares fell for seven straight sessions, as the stock was down 0.9% at $55.64 on Monday. The New Jersey-based pharma giant fell 3.5% in the preceding six sessions. The stock is down 5% over the past one month, while it has advanced 4% so far this year. Most recently, Bristol-Myers Squibb reported better-than-expected Q1 2...</div>

<p>Bristol-Myers Squibb (BMY) shares have declined for seven consecutive sessions, dropping 0.9% to $55.64 on Monday. The stock has fallen 3.5% in the previous six sessions and is down 5% over the past month, although it has increased 4% year-to-date. The company recently reported better-than-expected Q1 results.</p>

Bristol Myers Squibb

Health Care Select Sector SPDR

iShares Biotechnology ETF

Direxion Pharma & Medical Bull 3X

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

iShares US Pharma

Ark Genomic Revolution ETF

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

iShares Global Healthcare

ProShares Ultra Health Care ETF

VG Health

Invesco Nasdaq Biotechnology ETF

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

First Trust NYSE Arca Biotech Index Fd

Bristol-Myers Squibb Company

Bristol-Myers Squibb shares fell for seventh consecutive session